Jason is the co-leader of Barclay Damon LLP’s cannabis team. He primarily concentrates his practice on the nuanced processes of structuring, licensing, and maintaining compliant cannabis businesses at the federal, state, and local levels. He also loves solving complex tax and regulatory problems. Jason is the chair of the Policy Committee for the Cannabis Association of New York and the chair of the Tax Committee for the NYS Bar Association Cannabis Law Section.
Do you think there is a stigma around working in the cannabis industry and if so how do you work to overcome it?
As cannabis has become more available and as markets have matured, I haven’t experienced much stigma working in the cannabis industry, particularly as a service provider. In fact, the industry now attracts a lot of people who find it fascinating and exciting. As markets mature, hopefully more people who have been impacted by cannabis prohibition can benefit from the normalization of the cannabis industry.
How can the cannabis industry work with health care and academic professionals to educate consumers about the benefits and risks of cannabis use?
The cannabis industry can work with health care and academic professionals to educate consumers about the benefits and risks of cannabis use by advocating for and providing funding and resources to study cannabis and its benefits and risks. As long as cannabis remains a Schedule I substance, industry stakeholders will need to create avenues to research the benefits of cannabis so professionals can provide the best advice and guidance.
Where do you see the cannabis industry in New York 10 years from now?
Because of the mandates in the MRTA, New York will create a lot of successful small and midsize businesses and social equity owners. This approach should lead to a robust ecosystem that can create generational wealth for participants, particularly those from communities impacted by cannabis prohibition, as well as thousands of new jobs, and innovations in the cannabis industry.